Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-24-009538

Chief Financial Officer gave up 2,175 shares (to pay taxes)

  • Chief Financial Officer acquired 4,621 shares (grant or award)
  • Chief Financial Officer acquired 9,275 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eisenstadt Richard I Chief Financial Officer 2024-01-30 Option exercise +9,275 42,566 D: show line 1 in the form
Eisenstadt Richard I Chief Financial Officer 2024-01-30 Shares withheld for taxes −2,175 $9.80 $21,315 40,391 D: show line 2 in the form
Eisenstadt Richard I Chief Financial Officer 2024-01-31 Grant or award +4,621 $2.69 $12,430 45,012 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Eisenstadt Richard I Chief Financial Officer 2024-01-30 Option exercise · Restricted Stock Units −9,275 27,825 D: show line 4 in the form
Loading xslF345X05/tm244961-1_4seq1.xml…